May 07, 2019 6:10am EDT Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company
Apr 24, 2019 4:30pm EDT Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company
Apr 15, 2019 6:00am EDT Lexaria Bioscience Engages Oak Hill Financial Inc. to Provide Investor Relations Services
Apr 09, 2019 5:55am EDT Lexaria Bioscience Renews Contracts with Senior Management and Cancels Options
Feb 26, 2019 6:15am EST Lexaria Bioscience Comments on FDA Statement on Novel Nicotine Replacement Therapies
Feb 21, 2019 6:15am EST Cardiovascular Performance Improvements including Lower Blood Pressure Discovered from Human Clinical Trial using Lexaria's DehydraTECH(TM) Powered TurboCBD(TM) Capsules
Jan 17, 2019 8:30am EST Altria Group Invests Up to $12M in Lexaria Bioscience’s DehydraTECH™ Technology
Jan 15, 2019 11:39am EST Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH(TM) Technology for Oral Nicotine
